{"entity":{"type":"insider","cik":"0001708681","url":"/insider/0001708681","json_url":"/insider/0001708681.json","name":"Zago Wagner M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":7,"first":"2017-09-29","last":"2023-08-02","span_basis":"filed_date"},"name_variants":[{"name":"Zago Wagner M.","source":"filing","n_filings":7,"first_seen":"2017-09-29","last_seen":"2023-08-02"}],"transactions":[{"id":8213929,"accession":"0001140361-23-037713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-23-037713","line_url":"/filing/0001140361-23-037713","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":67.0453796,"price_display":"67.05","price_state":"stated","total_value":268181.5184,"total_display":"268,181.52","total_whole":"268,182","shares_owned_after":229.0,"shares_owned_after_display":"229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-02","scope":"insider","n_lines":2},{"id":8541512,"accession":"0001140361-23-033192","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-23-033192","line_url":"/filing/0001140361-23-033192","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":68.161956075,"price_display":"68.16","price_state":"stated","total_value":272647.8243,"total_display":"272,647.82","total_whole":"272,648","shares_owned_after":1009.0,"shares_owned_after_display":"1,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-05","scope":"insider","n_lines":2},{"id":8731217,"accession":"0001140361-23-028870","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-23-028870","line_url":"/filing/0001140361-23-028870","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":71.06442423157895,"price_display":"71.06","price_state":"stated","total_value":1350224.0604,"total_display":"1,350,224.06","total_whole":"1,350,224","shares_owned_after":4053.0,"shares_owned_after_display":"4,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-07","scope":"insider","n_lines":4},{"id":4241121,"accession":"0001567619-21-012571","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001567619-21-012571","line_url":"/filing/0001567619-21-012571","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115250.0,"shares_display":"115,250","price_per_share":46.149835825596526,"price_display":"46.15","price_state":"stated","total_value":5318768.5789,"total_display":"5,318,768.58","total_whole":"5,318,769","shares_owned_after":49410.0,"shares_owned_after_display":"49,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-24","scope":"insider","n_lines":4},{"id":4995635,"accession":"0001567619-21-004526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-004526","line_url":"/filing/0001567619-21-004526#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7540.0,"shares_display":"7,540","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":192270.0,"total_display":"192,270.00","total_whole":"192,270","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-19","scope":"insider"},{"id":5463867,"accession":"0001567619-21-004318","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-004318","line_url":"/filing/0001567619-21-004318","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26310.0,"shares_display":"26,310","price_per_share":19.15836944127708,"price_display":"19.16","price_state":"stated","total_value":504056.7,"total_display":"504,056.70","total_whole":"504,057","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-12","filed_date":"2021-02-17","scope":"insider","n_lines":2},{"id":4973915,"accession":"0000899243-17-022966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-022966","line_url":"/filing/0000899243-17-022966#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001708681","owner_name":"Zago Wagner M.","owner_display_name":"Zago Wagner M.","owner_url":"/insider/0001708681","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":63000.0,"total_display":"63,000.00","total_whole":"63,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-28","filed_date":"2017-09-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001559053","name":"PROTHENA CORP PUBLIC LTD CO","url":"/issuer/0001559053","role":"Officer (Chief Scientific Officer)","n_filings":7,"first_seen":"2017-09-29","last_seen":"2023-08-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001708681","retrieved_at":"2026-08-23T18:57:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}